Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 060106/0209 | |
| Pages: | 5 |
| | Recorded: | 06/06/2022 | | |
| Attorney Dkt #: | 650053.00871, 00685,00501 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/14/2022
|
Application #:
|
16647603
|
Filing Dt:
|
03/16/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/13/2020
| | | | |
|
Title:
|
SUBSTITUTED EPOXYEICOSATRIENOIC ACID (EET) ANALOGS FOR TREATMENT OF KIDNEY DISEASE
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17729918
|
Filing Dt:
|
04/26/2022
|
|
Publication #:
|
|
Pub Dt:
|
08/11/2022
| | | | |
|
Title:
|
KIDNEY-TARGETED EPOXYEICOSATRIENOIC ACID (EET) ANALOGS
|
|
|
Assignee
|
|
|
|
|
| 210 WEST 7TH STREET |
| AUSTIN, TEXAS 78701 |
|
|
Correspondence name and address
|
| |
JERE L POLMATIER
|
| |
QUARLES & BRADY LLP
|
| |
411 EAST WISCONSIN AVENUE, SUITE 2400
|
| |
MILWAUKEE, WI 53202
|
Search Results as of:
06/04/2024 03:50 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
